Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities
- 1 November 2016
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 124, 129-137
Abstract
No abstract availableKeywords
Funding Information
- University of Nebraska
- University of Nebraska Medical Center
- National Institutes of Health (PO1-AI083211)
- Fred & Pamela Buffett Cancer Center (P30CA036727)
This publication has 43 references indexed in Scilit:
- Marinopyrrole Derivatives as Potential Antibiotic Agents against Methicillin-Resistant Staphylococcus aureus (I)Marine Drugs, 2012
- National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010American Journal of Infection Control, 2012
- Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapyF1000 Medicine Reports, 2012
- Challenges of Antibacterial DiscoveryClinical Microbiology Reviews, 2011
- Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1)Xenobiotica, 2010
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Fluorine in Pharmaceuticals: Looking Beyond IntuitionScience, 2007
- Structure-Function Characterization and Optimization of a Plant-Derived Antibacterial PeptideAntimicrobial Agents and Chemotherapy, 2005
- Regio-selective hydroxysubstitution of fluorobenzoic acid derivatives: facile synthesis of fluorosalicylic acid derivativesJournal of Fluorine Chemistry, 2003
- A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead.Circulation, 1982